Cite
APA Citation
Vallejo-Vaz, A. J., Leiter, L. A., Del Prato, S., Taskinen, M., Müller-Wieland, D., Bujas-Bobanovic, M., Letierce, A., Mandel, J., Samuel, R., & Ray, K. K. (2020). triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab. European journal of preventive cardiology, 27, 1663–1674. http://access.bl.uk/ark:/81055/vdc_100107929075.0x000024